The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, ...
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 29-year-old woman was referred to Tufts Medical Center ...
Hosted on MSN
Early detection is key to improving treatment of uveitis, a global leading cause of vision loss
New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results